Lactotroph Pituitary Neuroendocrine Tumor

Lactotroph Pituitary Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03038308	Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole	completed	Phase 1 / Phase 2	16	Columbia UniversityOTHER	1	Jun 4, 2024	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials

Data updated 23 days agoSource updated Jun 4, 2024source: clinicaltrials